Filing Details

Form Type:
4
Zero Holdings:
No
Publication Time:
2009-05-27 08:14:58
Reporting Period:
2009-05-26
Issuer
Cik Name Symbol Sector (SIC) IRS No
1114220 Keryx Biopharmaceuticals Inc KERX ()
Insiders
Cik Name Reported Address Insider Title Director Officer Large Shareholder Other
1413525 P. Michael Tarnok C/O Keryx Biopharmaceuticals, Inc.
750 Lexington Avenue
New York NY 10022
Yes No No No
Reported Non-Derivative Transactions
Sec. Name Acquisiton - Disposition Date Amount Price Remaning Holdings Equity Swap Involved Form Type Code Nature of Ownership Explanation
Common Stock Acquisiton 2009-05-26 40,000 $0.46 191,100 No 4 P Direct
Equity Swap Involved Form Type Code Nature of Ownership Explanation
No 4 P Direct